NCT05205226View on ClinicalTrials.gov

Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment

CompletedOBSERVATIONAL
Enrollment

636

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

June 5, 2021

Study Completion Date

January 2, 2022

Conditions
Non Small Cell Lung Cancer
Trial Locations (1)

410013

Hunan Cancer Hospital, Changsha

All Listed Sponsors
lead

Hunan Province Tumor Hospital

OTHER

NCT05205226 - Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment | Biotech Hunter | Biotech Hunter